Publication Name	World Journal of Gastroenterology
Manuscript ID	97500
Country	China

Received	2024-08-23 02:47
Peer-Review Started	2024-05-31 13:14
To Make the First Decision
Return for Revision	2024-10-19 04:39
Revised	2024-11-02 01:57
Second Decision	2024-12-09 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-09 06:31
Articles in Press	2024-12-09 06:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-20 06:29
Publish the Manuscript Online	2024-12-30 09:49

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Opinion Review
Article Title	What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
Manuscript Source	Invited Manuscript
All Author List	Qin Pan, Qing-Yang Xu, Lang-Hua Zhang and Ya-Fang He
Funding Agency and Grant Number	Funding Agency Grant Number National Science and Technology Major Project of China 2023ZD0508700 National Natural Science Foundation of China 81470859 Program of Taizhou Science and Technology Grant 24ywb33
Corresponding Author	Ya-Fang He, PhD, Department of Pediatric Respiratory, Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China. heyafang@xinhuamed.com.cn
Key Words	Nonalcoholic fatty liver disease; Lung; Cancer; Adenocarcinoma; Metabolic syndrome; Component
Core Tip	The increasing incidence of nonalcoholic fatty liver disease (NAFLD) has led to a public health burden, which is even worse due to its close association with lung cancer. Limited understanding of this phenomenon hinders the prevention, diagnosis, and treatment of NAFLD-related lung cancer. This article presents the effects of NAFLD on the progression, pathological subtypes, metastasis, and treatment response of lung cancer. Moreover, the mechanisms underlying the NAFLD-related metabolic disorders, metabolic syndrome-dependent immune impairment and tumor growth are discussed. These findings may provide insights into the role of NAFLD in pulmonary carcinoma, and highlights new treatment strategies for this disease.
Publish Date	2024-12-30 09:49
Citation	<p>Pan Q, Xu QY, Zhang LH, He YF. What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? <i>World J Gastroenterol</i> 2025; 31(5): 97500</p>
URL	https://www.wjgnet.com/1007-9327/full/v31/i5/97500.htm
DOI	https://dx.doi.org/10.3748/wjg.v31.i5.97500

Full Article (PDF)	WJG-31-97500-with-cover.pdf
Manuscript File	97500_Auto_Edited_082449.docx
Answering Reviewers	97500-answering-reviewers.pdf
Audio Core Tip	97500-audio.m4a
Conflict-of-Interest Disclosure Form	97500-conflict-of-interest-statement.pdf
Copyright License Agreement	97500-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	97500-non-native-speakers.pdf
Peer-review Report	97500-peer-reviews.pdf
Scientific Misconduct Check	97500-scientific-misconduct-check.png
Scientific Editor Work List	97500-scientific-editor-work-list.pdf
CrossCheck Report	97500-crosscheck-report.pdf